Access content directly

Sebastien Benzekry



Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers

Célestin Bigarré , François Bertucci , Pascal Finetti , Gaëtan Macgrogan , Xavier Muracciole et al.
Computer Methods and Programs in Biomedicine, 2023, 231, pp.107401. ⟨10.1016/j.cmpb.2023.107401⟩
Journal articles hal-04008520v1

Des modèles mathématiques pour la recherche clinique en cancérologie

Sébastien Benzekry
Interstices, 2022
Journal articles hal-03746564v1
Image document

Macro-scale models for fluid flow in tumour tissues: impact of microstructure properties

Cristina Vaghi , Raphaëlle Fanciullino , Sébastien Benzekry , Clair Poignard
Journal of Mathematical Biology, 2022, 84, pp.27. ⟨10.1007/s00285-022-01719-1⟩
Journal articles hal-02891573v1

Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic

Anne Rodallec , Cristina Vaghi , Joseph Ciccolini , Raphaelle Fanciullino , Sebastien Benzekry et al.
PLoS ONE, 2022, 17 (9), pp.e0274886. ⟨10.1371/journal.pone.0274886⟩
Journal articles hal-03924541v1
Image document

Asymptotic analysis of a biphase tumor fluid flow: the weak coupling case.

Cristina Vaghi , Sébastien Benzekry , Clair Poignard
Applied Mathematics and Computation, 2022, 413, pp.126635. ⟨10.1016/j.amc.2021.126635⟩
Journal articles hal-03354766v1
Image document

Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma

Arturo Álvarez-Arenas , Wilfried Souleyreau , Andrea Emanuelli , Lindsay S Cooley , Jean-Christophe Bernhard et al.
PLoS Computational Biology, 2022, 18, ⟨10.1371/journal.pcbi.1010444⟩
Journal articles hal-03921339v1
Image document

Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis

Sébastien Benzekry , Coline Sentis , Carole Coze , Laëtitia Tessonnier , Nicolas André et al.
JCO Clinical Cancer Informatics, 2021, 5, pp.81-90. ⟨10.1200/CCI.20.00092⟩
Journal articles hal-03147049v1
Image document

Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data

Sébastien Benzekry , Mathieu Grangeon , Mélanie Karlsen , Maria Alexa , Isabella Bicalho-Frazeto et al.
Cancers, 2021, 13 (24), pp.6210. ⟨10.3390/cancers13246210⟩
Journal articles hal-03478003v2

Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression

Lindsay Cooley , Justine Rudewicz , Wilfried Souleyreau , Andrea Emanuelli , Arturo Alvarez-Arenas et al.
Molecular Cancer, 2021, 20 (1), ⟨10.1186/s12943-021-01416-5⟩
Journal articles hal-03390517v1
Image document

Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects

Joseph Ciccolini , Sébastien Benzekry , Fabrice Barlesi
British Journal of Cancer, 2020, 123 (3), pp.337-338. ⟨10.1038/s41416-020-0918-3⟩
Journal articles hal-03147110v1
Image document

Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology

Sébastien Benzekry
Clinical Pharmacology and Therapeutics, 2020, ⟨10.1002/cpt.1951⟩
Journal articles hal-02916941v1
Image document

Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors

Cristina Vaghi , Anne Rodallec , Raphaëlle Fanciullino , Joseph Ciccolini , Jonathan P Mochel et al.
PLoS Computational Biology, 2020, 16 (2), pp.e1007178. ⟨10.1371/journal.pcbi.1007178⟩
Journal articles inserm-02515955v1
Image document

Prédiction de l'efficacité de l'immunothérapie dans le cancer bronchique à partir de données cliniques et biologiques simples : apport de l'intelligence artificielle

Mathieu Grangeon , Sebastien Benzekry , Solène Chaleat , Pascale Tomasini , Dominique Barbolosi et al.
Revue des Maladies Respiratoires Actualites, 2020, 12 (1), pp.217. ⟨10.1016/j.rmra.2019.11.477⟩
Journal articles hal-03147118v1
Image document

Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer

Chiara Nicolò , Cynthia Périer , Mélanie Prague , Carine Bellera , Gaëtan Macgrogan et al.
JCO Clinical Cancer Informatics, 2020, 4, pp.259-274. ⟨10.1200/CCI.19.00133⟩
Journal articles hal-02942177v1
Image document

Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?

Joseph Ciccolini , Dominique Barbolosi , Nicolas André , Fabrice Barlesi , Sébastien Benzekry et al.
JCO precision oncology, 2020, 108 (4), pp.486-491. ⟨10.1200/PO.19.00381⟩
Journal articles hal-03147084v1
Image document

Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

Anne Rodallec , Raphaelle Fanciullino , Sébastien Benzekry , Joseph Ciccolini
Anticancer Research, 2019, 39 (7), pp.3419-3422. ⟨10.21873/anticanres.13486⟩
Journal articles hal-02383831v1
Image document

CAR T-Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies

Jonathan Paul M. Mochel , Stephen C Ekker , Chad Johannes , Albert E Jergens , Karin Allenspach et al.
AAPS Journal, 2019, 21 (3), ⟨10.1208/s12248-019-0322-1⟩
Journal articles hal-02099159v1
Image document

Optimal Scheduling of Bevacizumab and Pemetrexed/cisplatin Dosing in Non‐Small Cell Lung Cancer

Benjamin K Schneider , Arnaud Boyer , Joseph Ciccolini , Fabrice Barlesi , Kenneth Wang et al.
CPT: Pharmacometrics and Systems Pharmacology, 2019, ⟨10.1002/psp4.12415⟩
Journal articles hal-02109335v1
Image document

Combinatorial immunotherapy strategies : most gods throw dice, but fate plays chess

Joseph Ciccolini , Dominique Barbolosi , Nicolas Andre , Sébastien Benzekry , Fabrice Barlesi et al.
Annals of Oncology, 2019, ⟨10.1093/annonc/mdz297⟩
Journal articles hal-02383826v1
Image document

Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer

Maria Bilous , Cindy Serdjebi , Arnaud Boyer , Claudia Pouypoudat , Pascale Tomasini et al.
Scientific Reports, 2019, 9 (1), ⟨10.1038/s41598-019-49407-3⟩
Journal articles hal-01928442v2
Image document

Combinatorial immunotherapy strategies: most gods throw dice, but fate

Joseph Ciccolini , Dominique Barbolosi , Nicolas André , Sebastien Benzekry , Fabrice Barlesi et al.
Annals of Oncology, 2019, 30 (11), pp.1690-1691. ⟨10.1093/annonc/mdz297/5559268⟩
Journal articles hal-03147132v1
Image document

Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles

Anne Rodallec , Guillaume Sicard , Raphaelle Fanciullino , Sébastien Benzekry , Bruno Lacarelle et al.
Expert Opinion on Drug Metabolism and Toxicology, 2018, 14 (11), pp.1-9. ⟨10.1080/17425255.2018.1540588⟩
Journal articles hal-01958583v1
Image document

Pharmacokinetics variability: why nanoparticles are not magic bullets in oncology

Anne Rodallec , Sébastien Benzekry , Bruno Lacarelle , Joseph Ciccolini , Raphaelle Fanciullino et al.
Critical Reviews in Oncology/Hematology, 2018, 129, pp.1 - 12. ⟨10.1016/j.critrevonc.2018.06.008⟩
Journal articles hal-01821678v1
Image document

Revisiting bevacizumab + cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non-small cell lung carcinoma

Diane-Charlotte Imbs , Raouf El Cheikh , Arnaud Boyer , Joseph Ciccolini , Celine Mascaux et al.
CPT: Pharmacometrics and Systems Pharmacology, 2018, pp.1-9. ⟨10.1002/psp4.12265⟩
Journal articles hal-01624423v2

Etude de l'effet séquence bevacizumab/pemetrexed/cisplatine chez la souris porteuse de cancer du poumon non à petites cellules

Arnaud Boyer , Joseph Ciccolini , Céline Mascaux , Diane-Charlotte Imbs , Raouf El Cheikh et al.
Revue des Maladies Respiratoires, 2017, 34, ⟨10.1016/j.rmr.2016.10.110⟩
Journal articles hal-01540322v1
Image document

Model-driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis

Severine Mollard , Joseph Ciccolini , Diane-Charlotte Imbs , Raouf El Cheikh , Dominique Barbolosi et al.
Journal articles hal-01474679v1
Image document

Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas

Araceli M Henares-Molina , Sébastien Benzekry , Pedro C Lara , Marcial M García-Rojo , Víctor M Pérez-García et al.
Journal articles hal-01532505v1
Image document

Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth

Sébastien Benzekry , Clare Lamont , Dominique Barbolosi , Lynn Hlatky , Philip Hahnfeldt et al.
Journal articles hal-01566947v1

Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach

Madeleine Benguigui , Dror Alishekevitz , Michael Timaner , Dvir Shechter , Ziv Raviv et al.
Oncotarget, 2017, 9 (2), pp.2574-2590. ⟨10.18632/oncotarget.23514⟩
Journal articles hal-01672568v1
Image document

Les lois de la croissance tumorale

Sébastien Benzekry
Bibliothèque Tangente, 2016
Journal articles hal-01418295v1
Image document

Next generation metronomic chemotherapy - report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6 - 8 May 2016, Mumbai

Pan G Pantziarka , Lisa Hutchinson , Nicolas G André , Sébastien Benzekry , Francesco Bertolini et al.
Ecancermedicalscience, 2016, 10, ⟨10.3332/ecancer.2016.689⟩
Journal articles hal-01392473v1
Image document

Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach

Sébastien Benzekry , Amanda Tracz , Michalis Mastri , R. Corbelli , Dominique Barbolosi et al.
Cancer Research, 2016, 76 (3), pp.535 - 547. ⟨10.1158/0008-5472.CAN-15-1389⟩
Journal articles hal-01222046v2
Image document

In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling

Séverine Mollard , Raphaelle Fanciullino , Sarah Giacometti , Cindy Serdjebi , Sebastien Benzekry et al.
Scientific Reports, 2016, 6, pp.10. ⟨10.1038/srep36173⟩
Journal articles hal-01392861v1

Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy

R. Serre , Sébastien Benzekry , Laetitia Padovani , C. Meille , N. Andre et al.
Journal articles hal-01336779v1
Image document

Computational Modelling of Metastasis Development in Renal Cell Carcinoma

Etienne Baratchart , Sébastien Benzekry , Andreas Bikfalvi , Thierry Colin , Lindsay S. Cooley et al.
PLoS Computational Biology, 2015, 11 (11), ⟨10.1371/journal.pcbi.1004626⟩
Journal articles hal-01164834v2

Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression

Afshin Beheshti , Sebastien Benzekry , J. Tyson Mcdonald , Lili Ma , Michael Peluso et al.
Cancer Research, 2015, 75 (6), pp.10. ⟨10.1158/0008-5472.CAN-14-1053⟩
Journal articles hal-01132048v1
Image document

Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks

Sebastien Benzekry , Jack A Tuszynski , Edward A Rietman , Giannoula Lakka Klement
Biology Direct, 2015, pp.14. ⟨10.1186/s13062-015-0058-5⟩
Journal articles hal-01158313v1

Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support

Joseph Ciccolini , Sébastien Benzekry , Bruno Lacarelle , Dominique Barbolosi , Fabrice Barlesi et al.
Proceedings of the National Academy of Sciences of the United States of America, 2015, pp.1. ⟨10.1073/pnas.1506689112⟩
Journal articles hal-01168635v1
Image document

Metronomic Reloaded: Theoretical Models Bringing Chemotherapy into the Era of Precision Medicine

Sébastien Benzekry , Eddy Pasquier , Dominique Barbolosi , Bruno Lacarelle , Fabrice Barlési et al.
Seminars in Cancer Biology, 2015, pp.23. ⟨10.1016/j.semcancer.2015.09.002⟩
Journal articles hal-01195547v1
Image document

Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth

Sebastien Benzekry , Afshin Beheshti , Philip Hahnfeldt , Lynn Hlatky
Bio-protocol , 2015, 5 (21)
Journal articles hal-01222068v1
Image document

Global Dormancy of Metastases due to Systemic Inhibition of Angiogenesis

Sébastien Benzekry , Alberto Gandolfi , Philip Hahnfeldt
PLoS ONE, 2014, 9 (1), pp.e84249. ⟨10.1371/journal.pone.0084249⟩
Journal articles hal-00868592v3
Image document

Classical Mathematical Models for Description and Forecast of Experimental Tumor Growth

Sébastien Benzekry , Clare Lamont , Afshin Beheshti , Amanda Tracz , John M.L. Ebos et al.
PLoS Computational Biology, 2014, 10 (8), pp.e1003800. ⟨10.1371/journal.pcbi.1003800⟩
Journal articles hal-00922553v6
Image document

Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.

Sebastien Benzekry , Philip Hahnfeldt
Journal of Theoretical Biology, 2013, 335, pp.235-44. ⟨10.1016/j.jtbi.2013.06.036⟩
Journal articles hal-00836032v1

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.

Floriane Lignet , Sébastien Benzekry , Shelby Wilson , Frédérique Billy , Olivier Saut et al.
Journal of Theoretical Biology, 2013, 320, pp.86-99. ⟨10.1016/j.jtbi.2012.12.013⟩
Journal articles hal-00785876v1
Image document

Modeling the impact of anticancer agents on metastatic spreading

Sébastien Benzekry , Nicolas André , Assia Benabdallah , Joseph Ciccolini , Christian Faivre et al.
Mathematical Model Natural Phenomenon, 2012, 7 (1), pp 306--336. ⟨10.1051/mmnp/20127114⟩
Journal articles hal-00657724v1
Image document

A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology

Sébastien Benzekry , Guillemette Chapuisat , Joseph Ciccolini , Alice Erlinger , Florence Hubert et al.
Comptes rendus de l'Académie des sciences. Série I, Mathématique, 2012, 350, pp.23-28. ⟨10.1016/j.crma.2011.11.019⟩
Journal articles hal-00641476v2
Image document

Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers

Sebastien Benzekry
ESAIM: Mathematical Modelling and Numerical Analysis, 2012, 46 (2), pp.207-237
Journal articles hal-00518110v1
Image document

Passing to the limit 2D-1D in a model for metastatic growth

Sebastien Benzekry
Journal of Biological Dynamics, 2011, pp.10.1080/17513758.2011.568071. ⟨10.1080/17513758.2011.568071⟩
Journal articles hal-00521968v1
Image document

Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis

Sebastien Benzekry
Journal of Evolution Equations, 2011, 11 (1), pp.187-213
Journal articles hal-00516693v1
Image document

Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer

Sébastien Benzekry , Mélanie Karlsen , Abdessamad Elkaoutari , Suresh Vatakuti , Petter Curle et al.
World Conference on Pharmacometrics, Mar 2022, Cape Town, South Africa
Conference papers hal-03935768v1

Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial

Laurent Greillier , Florence Monville , Vanina Leca , Frédéric Vely , Stephane Garcia et al.
AACR, Apr 2022, New Orleans, United States. pp.LB120, ⟨10.1158/1538-7445.AM2022-LB120⟩
Conference papers hal-03926538v1
Image document

A mechanistic model for prediction of metastatic relapse in early-stage breast cancer using routine clinical features

Célestin Bigarré , Pascal Finetti , François Bertucci , Xavier Muracciole , Sébastien Benzekry et al.
AACR, Apr 2022, New Orléans, United States. pp.2737, ⟨10.1158/1538-7445.AM2022-2737⟩
Conference papers hal-03752407v1
Image document

3MO - Comprehensive biomarkers (BMs) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: a subgroup analysis of the Precision Immuno-Oncology for advanced Non-Small CEll Lung CancER (PIONeeR) trial

Fabrice Barlesi , Laurent Greillier , Florence Monville , C Audigier-Valette , S. Martinez et al.
ESMO Immuno-Oncology, Dec 2022, Geneva, Switzerland
Conference papers hal-03928784v1
Image document

Supporting decision making and early prediction of survival for oncology drug development using a pharmacometrics-machine learning based model

Sébastien Benzekry , Mélanie Karlsen , Abdessamad Elkaoutari , René Bruno , Aleš Neubert et al.
PAGE - Population Approach Group Europe, Jun 2022, Ljubljana, Slovenia
Conference papers hal-03921394v1
Image document

Mechanistic modeling of metastasis: cancer at the organism scale

Sébastien Benzekry
International Society of Pharmacometrics (ISoP) workshop, Jul 2019, Paris, France
Conference papers hal-02424424v1
Image document

Data-driven mechanistic modeling of metastasis: cancer at the organism scale

Sébastien Benzekry
RITS conference (Recherche en Imagerie et Technologies pour la Sante) of the French Society of Biomedical Engineering (SFGBM), May 2019, Tours, France
Conference papers hal-02424452v2
Image document

Machine learning versus mechanistic modeling for prediction of metastatic relapse in breast cancer

Sebastien Benzekry
2019 CSBC-PSON Mathematical Oncology Meeting, May 2019, Portland, United States
Conference papers hal-02424419v1
Image document

Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth

Sébastien Benzekry
3rd Mathematical Biology Modeling days of Besançon, Jun 2018, Besançon, France
Conference papers hal-01969102v1
Image document

Optimization of sequential administration of bevacizumab plus cytotoxics in non-small cell lung cancer by combining in vivo experiments and mathematical modeling

Sébastien Benzekry
Mathematical perspectives in the biology and therapeutics of cancer, Jul 2018, Marseille, France
Conference papers hal-01969142v1
Image document

Mathematical Modeling and Prediction of Clinical Metastasis

Sébastien Benzekry
Mathematical Challenges in the Analysis of Continuum Models for Cancer Growth, Evolution and Therapy, Nov 2018, Oaxaca, Mexico
Conference papers hal-01969108v1

Optimized radiotherapy protocols delay the malignant transformation of low-grade gliomas in-silico

Araceli Henares-Molina , Sébastien Benzekry , Pedro Lara , Marcial García-Rojo , Victor Pérez-García et al.
5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, May 2017, Zurich, Switzerland. pp.iii12 - iii12, ⟨10.1093/neuonc/nox036.040⟩
Conference papers hal-01517899v1

Abstract 2099: Model-driven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice

Joseph Ciccolini , Sebastien Benzekry , Sarah Giacometti , Fabrice Barlesi , Dominique Barbolosi et al.
107th Annual Meeting of the American Association for Cancer Research, 2016, New Orleans, France. pp.20, ⟨10.1158/1538-7445.AM2016-2099⟩
Conference papers hal-01404637v1
Image document

On the growth and dissemination laws in a mathematical model of metastatic growth

Sébastien Benzekry , John M.L. Ebos
Workshop on Multiscale and Hybrid Modelling in Cell and Cell Population Biology, Mar 2015, Paris, France. ⟨10.1051/itmconf/20150500007⟩
Conference papers hal-01222088v1

Model-based optimization of combined antiangiogenic + cytotoxics modalities: application to the bevacizumab-paclitaxel association in breast cancer models

Séverine Mollard , Sébastien Benzekry , Giacometti Sarah , Christian Faivre , Florence Hubert et al.
AACR Annual Meeting 2014, Apr 2014, San Diego, United States. ⟨10.1158/1538-7445.AM2014-3677⟩
Conference papers hal-01090883v1
Image document

A mathematical model of systemic inhibition of angiogenesis in metastatic development

Sébastien Benzekry , Alberto Gandolfi , Philip Hahnfeldt
Congres SMAI 2013, May 2013, Seignosse, France. pp.75-87, ⟨10.1051.201445008⟩
Conference papers hal-00867992v1
Image document

Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer

Sébastien Benzekry , Mélanie Karlsen , Abdessamad Elkaoutari , Suresh Vatakuti , Petter Curle et al.
compsyscan22 : A complex systems approach to cancer understanding, Oct 2022, Lyon, France
Conference poster hal-03935786v1
Image document

Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer

Sébastien Benzekry , Mélanie Karlsen , Abdessamad Elkaoutari , Suresh Vatakuti , Petter Curle et al.
Journée de la Recherche en Pharmacie, Oct 2022, Marseille, France
Conference poster hal-03935812v1
Image document

Machine Learning and Mechanistic Modeling for the prediction of Overall Survival on the basis of 1st line Tumor Dynamics in Head and Neck Squamous Cell Carcinoma

Kevin Atsou , Anne Auperin , Joêl Guigay , Sébastien Salas , Sébastien Benzekry et al.
Colloque Science numériques et intelligence Artificielle pour la Santé, AMU, Nov 2021, Marseille, France
Conference poster hal-03467230v1
Image document

Machine learning for prediction of immunotherapy efficacy in non-small cell lung cancer from simple clinical and biological data

Sébastien Benzekry , Mathieu Grangeon , Mélanie Karlsen , Pauline Fleury , Maria Alexa et al.
Colloque Sciences numériques et Intelligence Artificielle pour la Santé à Aix-Marseille Université, Nov 2021, Marseille, France. 2021
Conference poster hal-03467615v1
Image document

Population modeling of tumor growth curves, the reduced Gompertz model and prediction of the age of a tumor

Cristina Vaghi , Anne Rodallec , Raphaelle Fanciullino , Joseph Ciccolini , Jonathan Paul M. Mochel et al.
PAGE 2019 Twenty-eighth meeting, Jun 2019, Stockholm, Sweden
Conference poster hal-02424578v1
Image document

Improving the efficacy of anti-cancer nanoparticles with data-driven mathematical modeling

Cristina Vaghi , Anne Rodallec , Raphaelle Fanciullino , Joseph Ciccolini , Clair Poignard et al.
Data Science Summer School, Jun 2018, Palaiseau, France
Conference poster hal-01968959v1
Image document

Modeling Primary Tumor Dynamics of Human-to-Mouse Xenografted Non-Small Cell Lung Cancer in Response to Administration of Bevacizumab and Pemetrexed-Cisplatin

Benjamin Schneider , Arnaud Boyer , Joseph Ciccolini , Kenneth Wang , Martin E Fernandez-Zapico et al.
Population Approach Group in Europe (PAGE) Meeting 2018, May 2018, Montreux, Switzerland. 2018
Conference poster hal-01968942v1
Image document

Mathematical modeling of differential effects of neo-adjuvant Sunitinib on primary tumor and metastatic growth

Chiara Nicolò , Michalis Mastri , Amanda Tracz , John M.L. Ebos , Sébastien Benzekry et al.
AACR Annual Meeting 2018, Apr 2018, Chicago, United States. 78 (13 Supplement), pp.4264, 2018, ⟨10.1158/1538-7445.AM2018-4264⟩
Conference poster hal-01968917v1
Image document

A biologically-based mathematical model for prediction of metastatic relapse

Michalis Mastri , Cynthia Perier , Gaetan Macgrogan , John M.L. Ebos , Sébastien Benzekry et al.
17th Biennial Congress of the Metastasis Research Society, Aug 2018, Princeton, United States
Conference poster hal-01968980v1
Image document

Modeling, mathematical and numerical analysis of anti-cancerous therapies for metastatic cancers

Sébastien Benzekry
Analysis of PDEs [math.AP]. Université Aix-Marseille 1 – Université de Provence, 2011. English. ⟨NNT : ⟩
Theses tel-01658210v1
Image document

Contributions in Mathematical Oncology: When Theory Meets Reality

Sébastien Benzekry
Mathematics [math]. Université de Bordeaux, 2017
Habilitation à diriger des recherches tel-01658070v1